Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin 19 pseudogene (ENSG00000276945) is a non-coding DNA sequence similar to the gene encoding protocadherin 19 (PCDH19) but is classified as a pseudogene, meaning it does not produce a functional protein. Pseudogenes are considered nonfunctional genomic relics and do not have known biological activity, do not participate in diseases as direct causative agents, and are not considered therapeutic targets. Explanation and Context - Pseudogene status: The provided Ensembl ID (ENSG00000276945) refers to a pseudogene; therefore, it does not encode a functional protein product and cannot act as a receptor, enzyme, transporter, or other druggable target[3]. - Not a therapeutic target: Unlike the functional gene PCDH19 (ENSG00000165194), which is implicated in epilepsy syndromes and serves as a recognized target in neurodevelopmental disease biology[1][2][3][4], pseudogenes typically do not possess such clinical or therapeutic relevance. - No drugs or mechanisms: No drugs are designed to interact with pseudogenes, nor are there mechanisms of action, biomarker use, or safety concerns associated with them in therapy. If you intended to inquire about functional PCDH19, see ENSG00000165194 and its protein product, which is involved in cell adhesion in the nervous system and associated with epilepsy and neurodevelopmental disorders[1][2][3][4]. The pseudogene should not be mistaken for the gene encoding the active, clinically relevant protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin 19 pseudogene.